MaaT Pharma SA

EPA:MAAT.PA

7.52 (EUR) • At close November 13, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) EUR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 0.8610.8610.4250.4251.3780.6890.9360.4680.4940.2470.5870.2940.3850.193-0.568-0.5680.5680.568
Kosten van de omzet 0.2690.2690.2970.2970.4840.1420.4890.2850.2580.0360.3490.1520.0140.0140.1050.0160.0590
Brutowinst 0.5920.5920.1280.1280.8940.5470.4470.1830.2360.2110.2380.1420.3720.179-0.673-0.5840.5090.568
Brutowinstmarge 0.6880.6880.3010.3010.6490.7940.4780.3910.4780.8540.4050.4840.9650.931.1851.0270.8961
Onderzoek- en ontwikkelingskosten 6.3486.3485.6015.6019.654.8256.8443.4927.3283.6644.6622.3814.272.1923.2771.6882.6691.362
Algemene en administratieve kosten 1.4361.4361.2781.2781.0891.0890.9030.9031.0581.0580.7520.7520.5290.5290.5840.58400
Verkoop- en marketingkosten 0.1540.1540.0550.0550.2710.2710.1830.1830.070.070.1350.1350.0440.0440.050.0500
Verkoop-, algemene en administratieve kosten 1.591.591.3331.3332.5181.3592.121.0862.0691.1281.6880.8871.1410.5730.7330.3590.5450.275
Overige kosten -0.968-0.968-1.101000000000000000
Bedrijfskosten 6.976.975.8335.83412.1684.8188.9643.2819.3973.96.352.5995.4112.1714.010.9753.2141.637
Bedrijfsresultaat -6.378-6.378-5.705-5.704-11.274-4.268-8.517-3.094-9.161-3.684-6.112-2.456-5.171-1.991-4.115-1.558-3.273-1.069
Bedrijfsresultaat ratio -7.412-7.412-13.422-13.421-8.181-6.194-9.099-6.611-18.545-14.915-10.412-8.366-13.431-10.3437.2452.742-5.762-1.881
Totaal overige inkomsten en kosten netto -0.05-0.050.0640.0630.7390.050.472-0.0540.302-0.0250.2-0.0310.108-0.0320.218-0.0090.378-0.016
Inkomen voor belasting -6.428-6.428-5.641-5.641-10.535-4.218-8.045-3.148-8.859-3.709-5.912-2.486-5.063-2.023-3.897-1.567-2.895-1.084
Inkomen voor belasting ratio -7.47-7.47-13.273-13.273-7.645-6.121-8.595-6.726-17.933-15.014-10.072-8.47-13.151-10.5126.8612.758-5.097-1.908
Belastingkosten -1.620-1.5330-2.10-1.7490-1.4420-0.940-1.0160-0.7640-0.7270
Nettowinst -6.428-6.428-5.641-5.641-8.435-4.218-6.296-3.148-7.417-3.709-4.972-2.486-4.047-2.023-3.133-1.567-2.168-1.084
Nettowinstmarge -7.47-7.47-13.273-13.273-6.121-6.121-6.726-6.726-15.014-15.014-8.47-8.47-10.512-10.5125.5162.758-3.817-1.908
WPA (Winst Per Aandeel) -0.53-0.53-0.49-0.49-0.76-0.38-0.64-0.32-0.75-0.38-0.5-0.65-19.6-1.96-15.18-1.52-10.5-1.05
Verwaterde WPA -0.53-0.53-0.49-0.49-0.76-0.38-0.64-0.32-0.75-0.38-0.5-0.65-19.6-1.96-15.18-1.52-10.5-1.05
EBITDA -6.32-6.32-5.652-5.652-10.177-4.218-7.65-3.02-8.624-3.638-5.667-2.406-4.854-1.951-3.778-1.531-2.805-1.043
EBITDA ratio -7.344-7.344-13.299-13.299-8.036-6.122-8.84-6.452-18.168-14.729-10.101-8.196-13.055-10.1327.062.695-5.658-1.836